Ocular Therapeutix
OCUL
OCUL
71 hedge funds and large institutions have $380M invested in Ocular Therapeutix in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
32% less capital invested
Capital invested by funds: $557M → $380M (-$177M)
Holders
71
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$29M | |
| 2 | +$25.9M | |
| 3 | +$23.8M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$16M |
| 5 |
Jennison Associates
New York
|
+$13.2M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$16.8M | |
| 3 | -$13.7M | |
| 4 |
BP
Ballentine Partners
Waltham,
Massachusetts
|
-$8.82M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.99M |